Goldman Sachs analyst Nathan Race maintains Cigna (NYSE:CI) with a Neutral and raises the price target from $273 to $311.
HC Wainwright & Co. Initiates Coverage On MoonLake with Buy Rating, Announces Price Target of $28
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on MoonLake (NASDAQ:MLTX) with a Buy rating and announces Price Target of $28.